Palma Rocchi

Institut National de la Santé et de la Recherche Médicale, France 0000-0002-4383-4684

Born on april 2nd, 1972, married, one child. Group leader on Targeting Stress induced Proteins in Castration-Resistant Prostate Cancer, Centre de Recherche en Cancérologie de Marseille, UMR 1068 Inserm-Institut Paoli-Calmettes, 27 Bd. Leï Roure, BP 30059, 13273 Marseille Cedex 09, France (phone: +33 6 26 94 12 87 ; palma.rocchi@inserm.fr) Palma Rocchi received her PhD in 2002 from the Medicine Faculty of Marseille evaluating the molecular mechanisms involved in the castration-resistant prostate cancer (CRPC). In her three years as post-doctoral fellow in the University of British Columbia Prostate Centre in Dr Gleave’s Lab. Palma Rocchi completed her formation by receiving advance training in targeting genes associated with CR and treatment resistance in PC. She developed a drug (OGX-427) using oligonucleotide antisens and siRNA approach able to significantly dose-dependent down-regulate Hsp27 protein expression level. OGX-427 has been patented and obtained an international license by the University of British Columbia and Oncogenex and clinical trials phase II is now in process in Canada and United States to evaluate the effect of OGX-427 in patients with prostate and bladder cancer (http://www.oncogenex.ca/). She has now completed her post-doctoral fellowship and found a position as an independent senior investigator in PC translational research at the French National Institute for Health and Medical Research. She is now focus on translational research leading to improve treatment resistance in PC. Her principal research interest is focused drug discovery for the treatment of CRPC. Publications International revues (31), oral communication (27) and posters (44) at international meeting and patents (5)

Biography Updated on 21 May 2012

Scholarly Contributions [Data Provided by scopus]

download